Clinical trials: Aggressive B-cell NHL

Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)

Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas

• Completed
• Age: 18 years and older

Diffuse large B-cell lymphomas (DLBCL) are highly aggressive and heterogeneous B-cell lymphoma that would imminently be fatal without treatment.

Trial name

ExoReBLy (NCT03985696)

Testing

blood sample

Where

France

Volunteers

90 people, healthy volunteers welcome

Sponsor

University Hospital, Limoges